Gara Jalqabaatti › Saree Oljoo › Minnesota › Plymouth
Qorannoo klinikaalii Saree Oljoo Plymouth, MN keessatti
Qorannoo 8 Saree Oljoo f Plymouth fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Fairview Clinics and Surgery Center Maple Grove, Maple Grove · Miili 4 fagaatti
- Minnesota Oncology - Maple Grove, Maple Grove · Miili 4 fagaatti
- Ridgeview Medical Center, Waconia · Miili 20 fagaatti
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Minnesota Oncology-Sarah Cannon Research Institute, Maple Grove · Miili 4 fagaatti
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Namoota walitti qabaa jiraSadarkaa 3
- Fairview Clinics and Surgery Center Maple Grove, Maple Grove · Miili 4 fagaatti
- Minnesota Oncology - Maple Grove, Maple Grove · Miili 4 fagaatti
- Ridgeview Medical Center, Waconia · Miili 20 fagaatti
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Namoota walitti qabaa jiraSadarkaa 2/3
- Minnesota Oncology Hematology, Maple Grove · Miili 4 fagaatti
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Namoota walitti qabaa jiraSadarkaa 3
- Minnesota Oncology, Maple Grove · Miili 4 fagaatti
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Namoota walitti qabaa jiraSadarkaa 3
- Minnesota Oncology Hematology, P.A., Plymouth
- Minnesota Oncology Hematology, P.A., Maple Grove · Miili 4 fagaatti
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Namoota walitti qabaa jiraSadarkaa 3
- Fairview Clinics and Surgery Center Maple Grove, Maple Grove · Miili 4 fagaatti
- Ridgeview Medical Center, Waconia · Miili 20 fagaatti
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ridgeview Medical Center, Waconia · Miili 20 fagaatti
Qorannoo Saree Oljoo magaalota biroo keessatti
- New York City, NYQorannoo 136
- Houston, TXQorannoo 126
- Boston, MAQorannoo 112
- Nashville, TNQorannoo 81
- Los Angeles, CAQorannoo 73
- Edison, NJQorannoo 68
- St. Louis, MOQorannoo 64
- Queens, NYQorannoo 64
- Durham, NCQorannoo 64
- Chicago, ILQorannoo 59
- Philadelphia, PAQorannoo 56
- Dallas, TXQorannoo 55
Qorannoo biroo Plymouth keessatti
- Kansarii ColorectalQorannoo 9
- Kansara Qara'a Non-Small CellQorannoo 8
- Dhibee QaraQorannoo 7
- Kansarii ProstateQorannoo 6
- Kansarii KoloniiQorannoo 5
- Kansara Harkaa (Karsinomaa Seli Renal)Qorannoo 5
- MelanomaQorannoo 5
- Kansa EndometiriyaaliiQorannoo 4
- Kansarii OvariiQorannoo 4
- Kansarii RektumiiQorannoo 4
- Kansara MetastatikiiQorannoo 4
- Dukkana BladderQorannoo 3
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.